cataracts

Omeros Corporation (NASDAQ: OMER) has agreed to sell Omidria to Rayner Surgical Group Limited for an upfront payment of $125 million with an additional $200 million in commercial milestones. Omidria (phenylephrine and ketorolac intraocular solution) 1% / 0.3% is approved for...

This article was originally published on The Fresh Toast, and appears here with permission. With stigmas changing, more adults are turning to the medicinal benefits of CBD and marijuana to treat eye conditions like cataracts. “Studies have shown that THC, which is the active...